With competence and innovative strength
There are currently 20 known substances that can be applied transdermally. TS offers twelve of these substances as transdermal therapeutic systems, making many patients’ lives easier. In cooperation with its partners from the pharmaceutical industry, LTS has set milestones in terms of innovation.
ORAL THIN FILMS
Oral thin films – a new evolution step for active substances
Oral thin films contain the active substance as a film, which is taken orally and is dissolved immediately in the mouth or applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal tract.
Innovative transdermal technologies from LTS
LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the permanent further development of LTS TTS and LTS OTF technologies, the company also develops innovative microneedle and the ‘active LTS TTS’ technology.
LTS – your partner for innovative solutions
The development of new pharmaceutical drugs is a lengthy and complex process in which not every highly promising active substance eventually becomes a successful drug. This is often because developers only think to develop tablets, capsules or solutions – but LTS offers alternative, innovative approaches.